Alexandra holds a BSc in psychology with continued studies in neuroscience and pharmacology. She also holds an interdisciplinary Med. licentiate merging the fields of neuropharmacology, psychiatry and immunology. Her previous research focused on interaction between the immune- and neurotransmitter systems regarding psychotic disorders.
The experimental therapy laquinimod was seen to prevent the start of harmful immune responses and to disrupt the progression of multiple sclerosis (MS) in a mouse model of the disease. This finding ... Read more